Webinars

  • Medical Therapy of Glaucoma: New Targets and Drug Combinations

    Medical Therapy of Glaucoma: New Targets and Drug Combinations

    Sponsored by: AKH inc. + iVista Medical Education

    Educational Objectives:

    • Review the risk factors for glaucoma and the impact of increased intraocular pressure (IOP) on patient outcomes
    • Discuss the current use of existing and novel pharmacotherapies for patients with open angle glaucoma
    • Evaluate the clinical trials results of newly approved ocular hypotensive agents, including ROCK inhibitors and combination agents

  • Modernized Glaucoma Management with PERG for Early Detection and SLT for Early Treatment

    Modernized Glaucoma Management with PERG for Early Detection and SLT for Early Treatment

    Sponsored by: Diopsys & Ellex
    Diagnosing and managing glaucoma today requires both accuracy and efficiency. Indications of progression before the damage becomes permanent improves outcomes. Improved patient compliance assists the physician in attaining a good prognosis for his patient. Modern electrophysiology (or, practical objective function testing) can advance a doctor's diagnostic capabilities and improve the management of glaucoma at an earlier stage. SLT with its inherent benefits and repeatability has been moved to the forefront lowering IOP – the hallmark of glaucoma management. The use of both electrophysiology and SLT together helps improve outcomes, increases compliance, reduce costs to the patient and to healthcare as well.

    Recorded on June 7, 2018